Lamis K. Eldjerou
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Hematology top 5%
Papers in
- Hematology 10
- Hematopoietic Stem Cell Transplantation 5
- Oncology 15
- CAR-T cell therapy research 13
- Co-authors
- John R. Wingard (3 shared papers)Helen L. Leather (1 shared paper)Stephan A. Grupp (3 shared papers)Yanni Hao (2 shared papers)Theodore Willis Laetsch (2 shared papers)Patricia Ann Wood (2 shared papers)Hidefumi Hiramatsu (2 shared papers)Mai He (2 shared papers)
- Journals
- Blood (5 papers)Transplantation and Cellular Therapy (5 papers)Transfusion (2 papers)Pediatric Blood & Cancer (2 papers)Current Hematologic Malignancy Reports (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Lamis K. Eldjerou
26 papers receiving 3.1k citations
Lamis K. Eldjerou's Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 2.6k
- Hematology 412
- Immunology 402
- Genetics 467
- Pathology and Forensic Medicine 247
Countries citing papers authored by Lamis K. Eldjerou
This map shows the geographic impact of Lamis K. Eldjerou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamis K. Eldjerou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamis K. Eldjerou more than expected).
Fields of papers citing papers by Lamis K. Eldjerou
This network shows the impact of papers produced by Lamis K. Eldjerou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamis K. Eldjerou. The network helps show where Lamis K. Eldjerou may publish in the future.
Co-authors
The 25 scholars most cited alongside Lamis K. Eldjerou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells Hit paper breakdown → | 2018 | 2781 |
| 2 | 2021 | 52 | |
| 3 | 2021 | 51 | |
| 4 | GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas. | 2020 | 43 |
| 5 | 2010 | 39 | |
| 6 | 2012 | 30 | |
| 7 | 2015 | 26 | |
| 8 | 2017 | 25 | |
| 9 | 2011 | 20 | |
| 10 | ASBMT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells | 2018 | 20 |
| 11 | 2018 | 17 | |
| 12 | 2012 | 16 | |
| 13 | 2019 | 14 | |
| 14 | 2019 | 14 | |
| 15 | 2017 | 11 | |
| 16 | 2019 | 11 | |
| 17 | Economic Burden of Neurologic Toxicities Associated with Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States. | 2020 | 7 |
| 18 | 2015 | 6 | |
| 19 | 2019 | 6 | |
| 20 | 2018 | 5 |
About Lamis K. Eldjerou
Lamis K. Eldjerou is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Genetics and Genetics, having authored 27 papers that have together received 3.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Acute Lymphoblastic Leukemia research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Virus-based gene therapy research (5 papers), Biomedical Ethics and Regulation (3 papers), Biomedical and Engineering Education (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Oncology (2.6k citations), Hematology (412 citations), Immunology (402 citations), Genetics (467 citations) and Pathology and Forensic Medicine (247 citations). Lamis K. Eldjerou has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include John R. Wingard, Helen L. Leather, Stephan A. Grupp, Yanni Hao, Theodore Willis Laetsch, Patricia Ann Wood, Hidefumi Hiramatsu, Mai He, William Birdsall Slayton and María Juliana Arcila. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Transfusion, Pediatric Blood & Cancer and Current Hematologic Malignancy Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.